Research Interests
Clinical Trials for Pediatric Cancer
Selected Grants
Addressing Food Insecurity in Transplant and Cellular Therapy Patients with Healthcare-Community Partnerships
ResearchCo Investigator · Awarded by The University of Kansas Medical Center Research Institute, Inc · 2024 - 2029ALTE15N2 STUDY
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2017 - 2021COG Work Order AAML: 1031--Millennium Pharmaceuticals, Inc.
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2013 - 2021COG WORK ORDER: (PROJECT: EVERYCHILD (APEC14B1) PCR - COG FOUNDATION
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2015 - 2021COG WORK ORDER: (PROJECT: PEDIATRIC MATCH (APEC1621SC) PCR - COG FOUNDATION
ResearchPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2017 - 2020COG Work Order: AALL1131: Ph III Clofarabine in High Risk B ALL
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2015 - 2020COG WORK ORDER: BIQSFP AALL1131
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2016 - 2019A Phase I trial of pomalidomide for children with recurrent, progressive or refractory CNS tumors
Clinical TrialPrincipal Investigator · Awarded by St. Jude Children's Research Hospital · 2015 - 2017Pediatric Brain Tumor Consortium
Clinical TrialPrincipal Investigator · Awarded by St. Jude Children's Research Hospital · 2014 - 2017Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma
ResearchCo Investigator · Awarded by Alex's Lemonade Stand · 2013 - 2015COG Work Order AALL07P1--Millennium Pharmaceuticals, Inc.
Clinical TrialPrincipal Investigator · Awarded by Children's Hospital of Philadelphia · 2013 - 2015External Relationships
- Allterum Therapeutics
- Champions Oncology
- Johnson & Johnson
- MMS Holdings
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.